Decreasing ICU-associated Clostridioides difficile infection through fluoroquinolone restriction, the FIRST trial: a study protocol

INTRODUCTION: Clostridioides difficile infection (CDI) is one of the most common healthcare-associated infections in the USA, having high incidence in intensive care units (ICU). Antibiotic use increases risk of CDI, with fluoroquinolones (FQs) particularly implicated. In healthcare settings, antibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Safdar, Nasia, Parmasad, Vishala, Brown, Roger, Carayon, Pascale, Lepak, Alexander, O'Horo, John C, Schulz, Lucas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245435/
https://www.ncbi.nlm.nih.gov/pubmed/34187821
http://dx.doi.org/10.1136/bmjopen-2020-046480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245435/
https://www.ncbi.nlm.nih.gov/pubmed/34187821
http://dx.doi.org/10.1136/bmjopen-2020-046480

Ejemplares similares